论文部分内容阅读
对临床Ⅳ期黑色素瘤,目前仍无基于随机试验以期提高患者总生存率的治疗方法。在动物模型及Ⅰ期临床试验研究方面,来拉度胺显示了有效的抗黑色素瘤活性。该文报道该药物的Ⅱ期临床试验,比较2种给药剂量治疗转移性黑色素瘤的有效性及安
There are currently no treatments based on randomized trials to improve the overall survival of patients with stage IV melanoma. Lenalidomide exhibits potent anti-melanoma activity in animal models and phase I clinical trials. This article reports the Phase II clinical trial of the drug to compare the efficacy and safety of the two doses administered to treat metastatic melanoma